
Research News
-
Luxa Reports Vision Improvements in Clinical Trial of its RPE Stem Cell Therapy for Dry AMD
Patients with worse vision at trial enrollment had greatest vision improvements.
-
Neurotech’s Encapsulated Cell Technology Receives FDA Approval for Treatment of MacTel
The technology was previously funded by the Foundation for the treatment of retinitis pigmentosa and dry age-related macular degeneration.
-
Adverum Advancing Wet AMD Gene Therapy into Phase 3 Clinical Trials
In earlier clinical trials, the emerging gene therapy greatly reduced the treatment burden associated with injections of approved anti-VEGF therapies.
-
LCA4 Gene Therapy Restores Meaningful Vision for Blind Children
MeiraGTx hopes to apply for marketing approval in the UK for the gene therapy.
-
RD Fund Invests in Perceive Pharma for Development of Neuroprotective Therapies
Perceive Pharma is a spin out of Perceive Biotherapeutics.
-
Leber Congenital Amaurosis Research Advances
Recent developments in research on Leber congenital amaurosis
-
Age-Related Macular Degeneration Research Advances
Recent developments in research on age-related macular degeneration.
-
Retinitis Pigmentosa Research Advances
Recent developments in research on retinitis pigmentosa.
-
Stargardt Disease Research Advances
Recent developments in research on Stargardt disease